PATENT CLAIM ANALYSIS

Application Number: 16394610
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-08
Patent Classification: ["514", "394000"]

Abstract:
A drinkable pharmaceutical solution includes telmisartan or a pharmaceutically acceptable salt, hydrate or polymorph thereof, where the telmisartan has a concentration of 1 to 10 mg/ml within the drinkable pharmaceutical solution, and the drinkable pharmaceutical solution has a pH of 10.

Claim (Index 13):
A method of preparing a drinkable pharmaceutical solution, comprising:\n (a) dissolving telmisartan or a pharmaceutically acceptable salt, hydrate or polymorph thereof and one or more sugar alcohols in water and NaOH so as to obtain a pH of 10; and (b) adjusting the concentration of telmisartan in the solution to 1 to 10 mg/ml.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 100.0
- Lexical Diversity: 1.60714
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14469750', '13321216', '13687820', '10570697', '14071740']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7513463916122233
- 35 USC 102 Novelty (BERT): 0.5641606060382831
- Combined Prediction Score: 0.7326278130548293
- Mean Citation Score: 283.583444
- Max Citation Score: 436.93118
- Similarity Product: 409.2776233325732

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test